Skip to main content

Table 5 Mean (SD) annualized health-care costs (in dollars) for patients by second-step interventions

From: What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment

 

MDD-related

Non-MDD-related

Overall

Inpatient

Outpatient

ER

Total MDD

Inpatient

Outpatient

ER

Total non-MDD

 

Mean (SD)

Mean (SD)

Mean (SD)

Continued

165 (1,980)

1,163 (1,496)

5 (77)

1,333 (2,567)

1,129 (6,949)

3,790 (8,701)

158 (674)

5,077 (12,608)

7,916 (14,008)

Discontinued

490 (5,252)

1,207 (1,532)

16 (154)

1,714 (5,519)

1,441 (8,015)

4,735 (16,492)

250 (752)

6,426 (20,217)

9,263 (23,459)

Switch

635 (4,036)

1,594 (2,909)

17 (202)

2,246 (5,644)

2,401 (12,878)

5,103 (8,306)

313 (1,011)

7,817 (18,516)

12,189 (20,863)

Add-on

1,074 (6,873)

1,859 (4,171)

21 (324)

2,954 (8,390)

2,701 (19,719)

6,235 (13,461)

365 (1,494)

9,301 (26,426)

14,514 (30,044)

Wilcoxon P value

A, B, C, D, E

A, B, C, D, E

C, E, F

A, B, C, D, E, F

B, C, D, E

B, C, D, E

C, D, E, F

B, C, D, E

A, B, C, D, E

  1. A difference between switched and added cohort is statistically significant (P < 0.05), B difference between switched and discontinued cohort is statistically significant (P < 0.05), C difference between switched and continued cohort is statistically significant (P < 0.05), D difference between added and discontinued cohort is statistically significant (P < 0.05), E difference between added and continued cohort is statistically significant (P < 0.05), F difference between discontinued and continued cohort is statistically significant (P < 0.05).